<SEC-DOCUMENT>0001193125-19-050027.txt : 20190225
<SEC-HEADER>0001193125-19-050027.hdr.sgml : 20190225
<ACCEPTANCE-DATETIME>20190225170534
ACCESSION NUMBER:		0001193125-19-050027
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190221
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190225
DATE AS OF CHANGE:		20190225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HCA Healthcare, Inc.
		CENTRAL INDEX KEY:			0000860730
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				273865930
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11239
		FILM NUMBER:		19630362

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARK PLZ
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		6153449551

	MAIL ADDRESS:	
		STREET 1:		ONE PARK PLAZA
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA Holdings, Inc.
		DATE OF NAME CHANGE:	20101126

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA INC/TN
		DATE OF NAME CHANGE:	20010627

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA THE HEALTHCARE CO
		DATE OF NAME CHANGE:	20010419
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d709968d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): February&nbsp;25, 2019 (February 21, 2019) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>HCA HEALTHCARE, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-11239</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">27-3865930</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Jurisdiction</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of
Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Commission File Number)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One Park Plaza, Nashville, Tennessee 37203 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices) (Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(615) <FONT STYLE="white-space:nowrap">344-9551</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s Telephone Number, Including Area Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
Name or Former Address, if Changed Since Last Report) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17
CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT
STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company &#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act. &#9744; </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers. </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Appointment of Meg G. Crofton to the Board of Directors of the
Company</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;21, 2019, HCA Healthcare, Inc. (the &#147;Company&#148;) announced that the Board of Directors of the Company
(the &#147;Board&#148;) has, based on the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Meg G. Crofton to the Company&#146;s Board effective March 1, 2019, increasing the number of directors on the Board
from 12 to 13. Ms.&nbsp;Crofton will serve on the Board&#146;s Compensation Committee and Patient Safety and Quality of Care Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Crofton was appointed to the Board pursuant to the Company&#146;s Amended and Restated Certificate of Incorporation, which provides
that a majority of directors on the Board may determine the number of directors which shall constitute the Board and that the Board may fill a newly created directorship resulting from any increase in the number of directors on the Board. There is
no arrangement or understanding between Ms.&nbsp;Crofton and any other person pursuant to which Ms.&nbsp;Crofton was selected as a director on the Board, nor is Ms.&nbsp;Crofton a member of the family of any executive officer of the Company or of
any other director on the Board. There have been no transactions, proposed or otherwise, in which Ms.&nbsp;Crofton participated or will participate that would be required to be disclosed herein pursuant to Item 404(a) of Regulation <FONT
STYLE="white-space:nowrap">S-K.</FONT> Ms.&nbsp;Crofton will participate in the compensation program the Company maintains for its <FONT STYLE="white-space:nowrap">non-management</FONT> directors, which compensation program was described in the
Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> the Company filed with the Securities and Exchange Commission on May&nbsp;2, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the press release issued by the Company announcing Ms.&nbsp;Crofton&#146;s appointment to the Board is attached hereto as <U>Exhibit
99.1</U> and incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Retirement of Ann H. Lamont from the Board of Directors of the Company</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;21, 2019, Ann H. Lamont informed the Company that she will step down from her position as a member of the Board of Directors
of the Company at the conclusion of her term at the 2019 annual meeting of the Company&#146;s stockholders. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and Exhibits. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;Exhibits. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>&nbsp;&nbsp;&nbsp;No.&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d709968dex991.htm">Press Release, dated February&nbsp;21, 2019 </A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date: February&nbsp;25, 2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">HCA HEALTHCARE, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ John M. Franck II</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John M. Franck II</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Vice President &#150;
Legal and Corporate Secretary</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d709968dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:48pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #000000">


<IMG SRC="g709968image000150.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-BOTTOM:1.00pt solid #000000"><B>news</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>FOR&nbsp;IMMEDIATE&nbsp;RELEASE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INVESTOR CONTACT:</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Kimbrough</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">615-344-2688</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MEDIA&nbsp;CONTACT:</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ed Fishbough</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">615-344-2810</FONT></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>HCA HEALTHCARE APPOINTS MEG CROFTON AS NEW </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>INDEPENDENT DIRECTOR </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NASHVILLE, Tenn.,
February</B><B></B><B>&nbsp;21, 2019</B> &#150; HCA Healthcare (NYSE: HCA) today announced that its board of directors has appointed Meg Crofton as an independent director, effective March&nbsp;1, 2019. With her addition, HCA Healthcare&#146;s board
of directors increases from 12 to 13 members. Ms.&nbsp;Crofton will also serve as a member of HCA Healthcare&#146;s compensation committee and patient safety and quality of care committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Crofton spent the majority of her professional career at The Walt Disney Company (NYSE: DIS) (&#147;Disney&#148;) until her retirement in 2015.
During her tenure at Disney, Ms.&nbsp;Crofton held positions of increasing responsibility, most recently as president of Disney&#146;s parks and resorts operations, U.S. and France. From 2006 to 2013, Ms.&nbsp;Crofton also served as president of
Walt Disney World, the largest site in Disney&#146;s parks and resorts division. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Meg Crofton&#146;s career-long commitment to exceptional customer
service is reflected in her more than three decades of experience at one of the world&#146;s leading hospitality corporations,&#148; said Sam Hazen, CEO of HCA Healthcare. &#147;Meg&#146;s experience and expertise will greatly complement HCA
Healthcare&#146;s patient-centered focus on the care and improvement of human life. We could not be more excited to announce her decision to join our Board.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Crofton holds a B.A. in marketing and an M.B.A. from Florida State University. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About HCA Healthcare </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nashville-based HCA Healthcare is
one of the nation&#146;s leading providers of healthcare services, comprising 185 hospitals and approximately 1,800 sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 21 states and the United
Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has
conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU
patients by 44&nbsp;percent. HCA Healthcare is a learning healthcare system that uses its more than 31&nbsp;million annual patient encounters to advance science, improve patient care and save lives. Please <U>click here</U> to connect with HCA
Healthcare on social media. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>All
references to &#147;Company,&#148; &#147;HCA&#148; and &#147;HCA Healthcare&#148; as used throughout this document refer to HCA Healthcare, Inc. and its affiliates. </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g709968image000150.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g709968image000150.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K JMUJ^FL7*S0K42MN*XMKJ&O%J^+L "P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV ;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N W 7<BMT0W9;>'-ZB
MWRG?K^ VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#  @%!@<&!0@'
M!@<)" @)#!,,# L+#!@1$@X3'!@='1L8&QH?(RPE'R$J(1H;)C0G*BXO,3(Q
M'B4V.C8P.BPP,3#_VP!# 0@)"0P*#!<,#!<P(!L@,# P,# P,# P,# P,# P
M,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,##_P  1" !4 /4#
M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M%@Y2!5/$SCAI??N%]O3)J[\ O!<?B/Q%)JFHQ;[#2RK!",K+,>5!]0,;B/\
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M93G! & 0>_?OS76URM6-@HHK@_&GB[Q9I>HSV7AWP;-J*(BF.]:7]VS$ GY
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<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
